The EPS projection of Benefitfocus, Inc. (NASDAQ:BNFT) for quarter ended 2016-09-30 is $-0.41. Last week, the projection for EPS was $-0.41 against target of $-0.41, a month earlier. While 2-months ago, this projection was $-0.41 versus forecast of $-0.41a quarter months earlier, posting a deviation of 0%.
Benefitfocus, Inc. (NASDAQ:BNFT) posted that 18 days earlier, the share price was revised 4 times on upside. In addition, negative revisions were 0.
In last week, negative EPS revisions were 0 times and positive EPS revisions were 0 times. In last one-month and two month the positive revisions were 0 and 0. While in last 120 and 90 days, positive revisions were 0, and 0, correspondingly.
The per-share earnings downgrade for Benefitfocus, Inc. (NASDAQ:BNFT) in the preceding 30 and 120 were 0 and 4. While in 60 and 90 days were 0, and 4, in that order.
Benefitfocus, Inc. (NASDAQ:BNFT) EPS target was $-0.41 for the quarter closed 1. It was based on 5 calls. As on 2016-05-04 the EPS was $-0.46. The change was $0.04, posting a deviation of 8%. The price projections gave a standard deviation of 0.02.
Quarterly Sales Estimates
Benefitfocus, Inc. (NASDAQ:BNFT) sales prediction for the fiscal 2017 stands at $79.5 and the median estimate is at $77.75. Almost 3 analysts gave sales target.
Among this, the highest sales estimate is $83.95 while the lowest target is $76.8 showing standard deviation of 3.882%.
As many as 3 analysts have positive sales targets revision while 3 reduced sales estimates, posting a deviation of 0%.
Last month, 3 experts have positive sales number revision. Also, 3 research groups lowered the sales projections, posting a deviation of 0%.
A quarter ago, 3 hiked sales target and 3 reduced sales forecast, posting a deviation of -3.518%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...